00:00 Introduction to Lung Cancer and Its Challenges02:32 Understanding Treatment Options for Lung Cancer05:22 The Evolution of Immunotherapy08:00 Immutep's Innovative Approach to Cancer Treatment10:39 Clinical Trials and Promising Data13:47 Collaboration with Merck and Future Prospects25:48 Clinical Trials and Efficacy Analysis28:03 Commercial Opportunities in Oncology31:15 Acquisition Trends in Biotech31:38 Advancements in Head and Neck Cancer Treatment37:32 Exploring Autoimmune Disease Treatments45:26 Financial Strategies and Investment Priorities
- Forums
- ASX - By Stock
- IMM
- Long form Immutep interview with CEO Marc Voigt
IMM
immutep limited
Add to My Watchlist
4.26%
!
24.5¢

Long form Immutep interview with CEO Marc Voigt
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
24.5¢ |
Change
0.010(4.26%) |
Mkt cap ! $359.6M |
Open | High | Low | Value | Volume |
24.0¢ | 24.8¢ | 23.5¢ | $309.7K | 1.278M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 435058 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.5¢ | 108906 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 435058 | 0.240 |
15 | 1640089 | 0.235 |
15 | 261428 | 0.230 |
20 | 527442 | 0.225 |
17 | 570614 | 0.220 |
Price($) | Vol. | No. |
---|---|---|
0.245 | 108906 | 5 |
0.250 | 357680 | 4 |
0.255 | 341400 | 6 |
0.260 | 287631 | 10 |
0.265 | 270000 | 5 |
Last trade - 16.10pm 08/09/2025 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |